Stanton L. Gerson

发表

DNA repair modulates the vulnerability of the developing brain to alkylating agents.

L. Samson, G. Kisby, M. Churchwell, 2009, DNA repair.

Human bone marrow-derived mesenchymal (stromal) progenitor cells (MPCs) cannot be recovered from peripheral blood progenitor cell collections.

S. Gerson, A. Caplan, H. Lazarus, 1997, Journal of hematotherapy.

Eradication of neuroblastoma cells in vitro by monoclonal antibody and human complement: method for purging autologous bone marrow.

N. Cheung, S. Gerson, P. Coccia, 1985, Cancer research.

Endothelial Kruppel-like factor 4 protects against atherothrombosis in mice.

A. Schmaier, D. Simon, S. Gerson, 2012, The Journal of clinical investigation.

Temozolomide: the effect of once- and twice-a-day dosing on tumor tissue levels of the DNA repair protein O(6)-alkylguanine-DNA-alkyltransferase.

J. Haaga, J. Willson, S. Gerson, 2001, Clinical Cancer Research.

O6-benzylguanine: a clinical trial establishing the biochemical modulatory dose in tumor tissue for alkyltransferase-directed DNA repair.

J. Haaga, J. Willson, C. Hoppel, 1999, Cancer research.

Quantitative immunohistochemical estimates of O6-alkylguanine-DNA alkyltransferase expression in normal and malignant human colon.

S. Gerson, L. Liu, N. H. Zaidi, 1996, Clinical cancer research : an official journal of the American Association for Cancer Research.

Comparison of O6-alkylguanine-DNA alkyltransferase activity based on cellular DNA content in human, rat and mouse tissues.

N. Berger, S. Gerson, K. Miller, 1986, Carcinogenesis.

Gene therapy and translational cancer research.

Stanton L. Gerson, Chi V. Dang, Marcia Litwak, 1999, Clinical cancer research : an official journal of the American Association for Cancer Research.

Carmustine and streptozocin in refractory melanoma: an attempt at modulation of O-alkylguanine-DNA-alkyltransferase.

R. Day, J. Kirkwood, D. Smith, 1996, Clinical cancer research : an official journal of the American Association for Cancer Research.

Increase in nitrosourea resistance in mammalian cells by retrovirally mediated gene transfer of bacterial O6-alkylguanine-DNA alkyltransferase.

M. Hatzoglou, S. Abboud, S. Gerson, 1989, Cancer research.

Splenectomy and the induction of murine colon cancer.

S. Gerson, T. Stellato, N. Gordon, 1988, Archives of surgery.

Serodiagnosis of invasive aspergillosis in patients with hematologic malignancy: validation of the Aspergillus fumigatus antigen radioimmunoassay.

S. Gerson, G. Talbot, S. Hurwitz, 1987, The Journal of infectious diseases.

Modulation of nitrosourea resistance in myeloid leukemias.

S. Gerson, J. Trey, Stanton L. Gerson, 1988, Blood.

Randomized cross-over trial of progenitor-cell mobilization: high-dose cyclophosphamide plus granulocyte colony-stimulating factor (G-CSF) versus granulocyte-macrophage colony-stimulating factor plus G-CSF.

L. Kutteh, S. Gerson, H. Lazarus, 2000, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Role of DNA repair in resistance to drugs that alkylate O6 of guanine.

J. Allay, S. Gerson, O. Koç, 1996, Cancer treatment and research.

Sequential tumor biopsies in early phase clinical trials of anticancer agents for pharmacodynamic evaluation.

J. Haaga, J. Willson, S. J. Berger, 2001, Clinical cancer research : an official journal of the American Association for Cancer Research.

Pulmonary Cavitation and Massive Hemoptysis in Invasive Pulmonary Aspergillosis

Stanton L. Gerson, S. Albelda, Peter A. Cassileth, 2015 .

Synergistic efficacy of O6-benzylguanine and 1,3-bis(2-chloroethyl)-1-nitrosourea (BCNU) in a human colon cancer xenograft completely resistant to BCNU alone.

J. Willson, S. Gerson, E. Zborowska, 1993, Biochemical pharmacology.

O6-alkylguanine-DNA alkyltransferase. A target for the modulation of drug resistance.

J. Willson, S. Gerson, Stanton L. Gerson, 1995, Hematology/oncology clinics of North America.

O6-methylguanine-DNA methyltransferase (MGMT) transfectants of a 1,3-bis(2-chloroethyl)-1-nitrosourea (BCNU)-sensitive colon cancer cell line selectively repopulate heterogenous MGMT+/MGMT- xenografts after BCNU and O6-benzylguanine plus BCNU.

J. Willson, S. Markowitz, S. Gerson, 1997, Cancer Research.

Bax deficiency extends the survival of Ku70 knockout mice that develop lung and heart diseases

B. Hoit, P. Hasty, S. Gerson, 2015, Cell Death and Disease.

Retroviral transduction and expression of the human alkyltransferase cDNA provides nitrosourea resistance to hematopoietic cells.

J. Allay, S. Gerson, O. Koç, 1995, Blood.

Retroviral-mediated gene transduction of human alkyltransferase complementary DNA confers nitrosourea resistance to human hematopoietic progenitors.

J. Allay, S. Gerson, O. Koç, 1996, Clinical cancer research : an official journal of the American Association for Cancer Research.

Amendment history : Erratum ( May 2016 ) Matricellular protein CCN 3 mitigates abdominal aortic aneurysm

J. Golledge, J. Moxon, P. Norman, 2018 .